Clinical Trial Update: ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of ASA404 or placebo with paclitaxel and carboplatin as first-line treatment for stage IIIb/IV non-small cell lung cancer; trial terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ASA404 (vadimezan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED